CONTEXT: Commercial announcement of a large Latin American hospital tying up with a provider of RWD platforms to help generate additional RWE in Latin America. IMPACT: Low READ TIME: 1 Continue Reading
CONTEXT: One for the Health economists This article shows the actual monetary value of RWR and how it can improve access to important pre-natal screening tests | US only data. IMPACT: Continue Reading
CONTEXT: An interesting article pointing out that the lab may not be the best place to get the overall view of how people behave in the real world | Not sure Continue Reading
CONTEXT: European politics aside (and there are so many wheels within wheels on that one!) there are many RWR / RWE topics exposed in this opinion piece. Not least of Continue Reading
CONTEXT: Conference presentation of a real-world feasibility study in NSCLC treatment with afatinib and the impact of NRG1 fusions. IMPACT: Medium READ TIME: 2 mins Quality Level Mean [1 – Continue Reading
CONTEXT: Virtual ASCO presentation of a retrospective chart review on prostate cancer treatments. IMPACT: Medium READ TIME: 2 mins Quality Level Mean [1 – 10]: 8 1. “Results from a Continue Reading
CONTEXT: Commercial announcement of a tie up to examine RWD sources for respiratory disease | Timely with the impact COVID has had on respiratory compromised patients | Use of natural language Continue Reading
CONTEXT: An interesting article on how our industry is so slow to adapt to change or is it that we cling to what we know and love? Either way, the Continue Reading
CONTEXT: Large scale ophthalmic registry results re-enforce the need for early detection and treatment of age-related macular degeneration (AMD) | US data only, American Academy of Ophthalmology IRIS registry is the Continue Reading
CONTEXT: Pragmatic Clinical Trial | Large scale studies like this, whilst technically an RCT, look and feel like RWR and with a very tangible goal in mind | Anything to Continue Reading
